Growth hormone after oral glucose overload: revision of reference values in normal subjects.

Arq Bras Endocrinol Metabol

Laboratório ANALYSA, Belo Horizonte, MG, Brasil.

Published: October 2008

The evaluation of growth hormone (GH) secretion continues to be important in acromegaly and the nadir GH (n-GH) level in the oral glucose tolerance test (OGTT) is the gold standard for the demonstration of secretory autonomy of this hormone. n-GH levels < 1 microg/L are defined as normal suppression but, using current assays, n-GH < 1 microg/L is detected in patients with untreated acromegaly and this value seems to be much lower in normal subjects. The objective of the present study was to evaluate n-GH levels in the OGTT in normal subjects using three different assays (GH ICMA Immulite; GH IRMA DSL and GH IFMA AutoDelfia). Two-hundred apparently healthy subjects (120 women) ranging in age from 18 to 70 years and with a BMI > 18.5 and < 27 kg/m(2), who used no medications and presented normal glycemia, blood count, albumin, creatinine, TSH, SGOT, SGPT and bilirubin were studied. Serum samples were obtained before and 30,60,90 and 120 min after oral administration of 75 g glucose. The test was repeated after 4 weeks in 157 participants, with the same protocol being used in 79 and 78 receiving an overload of 100 g glucose. n-GH cut-off values (97.5th percentile) were higher in women than in men (GH-IFMA: 0.30 versus 0.11 microg/L; GH-ICMA: 0.60 versus 0.25 microg/L; GH-IRMA: 0.20 versus 0.10 microg/L, respectively). No correlation was observed between n-GH and age or BMI. A difference was only observed when comparing women < 35 years (n = 40) versus > 35 years (n = 80), with higher values in the former (n-GH cut-off in this subgroup: GH-IFMA 0.40 versus 0.26 microg/L, GH-ICMA 0.74 versus 0.50 microg/L, GH-IRMA 0.25 versus 0.15 microg/L). A good correlation was observed between the assays (r = 0.9-0.96), however, the highest values were always obtained with the Immulite assay. Test repetition with 75 g oral glucose showed a variation in n-GH < 10.2% (GH-IFMA), < 13.4% (GH-ICMA) and < 11% (GH-IRMA) in 95% of the subjects. This variation was similar when the test was repeated with 100 g glucose. A good correlation was observed between n-GH in the first and second test (r = 0.83-0.92). We suggest the following n-GH reference values: for men, 0.14 microg/L for the GH IRMA DSL and GH IFMA AutoDelfia kits and 0.25 microg/L for the GH ICMA Immulite kit; for women, 0.25 microg/L, 0.40 microg/L and 0.70 microg/L, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0004-27302008000700010DOI Listing

Publication Analysis

Top Keywords

microg/l
13
oral glucose
12
normal subjects
12
025 microg/l
12
correlation observed
12
n-gh
10
growth hormone
8
reference values
8
n-gh levels
8
icma immulite
8

Similar Publications

Article Synopsis
  • Laryngeal neuroendocrine tumors (NETs) are very rare, making up less than 1% of laryngeal cancers, and calcitonin-secreting types are even more uncommon.
  • A 71-year-old woman diagnosed with a small cell undifferentiated neuroendocrine carcinoma underwent multiple treatments, including chemotherapy, which led to some initial success but later relapsed with increased calcitonin levels.
  • The case highlights the difficulties in diagnosing and treating laryngeal NETs, particularly regarding the role of serum calcitonin levels in tracking disease persistence and treatment response.
View Article and Find Full Text PDF

Background: Calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) are an effective treatment of migraine however may have possible off-target effects. Pre-clinical studies implicate CGRP in several aspects of bone turnover and homeostasis. The clinical effect of CGRP mAb on bone turnover is not known, however.

View Article and Find Full Text PDF

Objective: To test the equivalence of two doses of intravenous iron (ferric carboxymaltose) in pregnancy.

Design: Parallel, two-arm equivalence randomised controlled trial with an equivalence margin of 5%.

Setting: Single centre in Australia.

View Article and Find Full Text PDF

Intracranial hypertension associated with arthroprosthetic cobaltism?

Am J Ophthalmol Case Rep

March 2022

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA.

Purpose: The purpose of this case report was to detail a unique patient with proven systemic cobaltism from metal-on-metal prosthetic hip articulation who then presented with clinical and radiographic signs of increased intracranial pressure.

Observations: A 59-year-old man with a past medical history of degenerative joint disease of the hip that status post total hip arthroplasty with cobalt-chromium implant presented with clinical and radiographic signs of increased intracranial hypertension. He underwent a revision arthroplasty with local debridement and removal of the cobalt-chromium implant and his serum cobalt level was elevated at 0.

View Article and Find Full Text PDF

Iodine is essential in the biosynthesis of thyroid hormones that affect metabolic processes in the organism from the prenatal state to the elderly. The immediate indicator of iodine intake is the concentration of iodine in urine, but the indicator of iodine intake in the longer term of several months is thyroglobulin (Tg). Tg negatively correlated with increasing intake of iodine in population that do not suffer from thyroid disease, while a more than adequate to excessive iodine intake leads to an increase in Tg.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!